Oliver Dorigo, MD, PhD, explains how MVP-S leverages the DPX platform to produce persistent anti-survivin immune infiltration, highlights the antitumor activity and safety observed with the combination when given to patients with recurrent ovarian cancer, and describes additional research efforts underway.
The Ovarian Cancer Research Alliance is drawing attention to the role of fallopian tubes in many cases of ovarian cancer and now says more women, including those with average risk, should consider having their tubes removed to cut their cancer risk.
Women at high risk of ovarian cancer should consider fallopian tube removal, experts say wxow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wxow.com Daily Mail and Mail on Sunday newspapers.